Nasdaq biol.
What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.
BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -...BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.BIOLASE, Inc. (NASDAQ:BIOL) shares gained 16.7% to close at $0.56 after jumping over 26% on Monday. BIOLASE, earlier during the month, announced a collaboration with BMW Performance Center West.(NASDAQ: BIOL) Biolase stock price per share is $1.24 today (as of Nov 24, 2023). What is Biolase's Market Cap? ( NASDAQ : BIOL ) Biolase 's market cap is $2.85M , as of Nov …BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ...
Mar 1, 2022 · 01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...
Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. BIOLASE (NASDAQ:BIOL – Get Free Report) last posted its earnings results on Thursday, August 10th. The medical technology company reported ($8.93) earnings per share (EPS) for the quarter.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. BIOLASE, Inc.(NASDAQ: BIOL), the global ...FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth ...Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...
How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.
(NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin ...
LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ...These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 24, 2023...BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupTodd Norbe -...H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused …
Jan 10, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ... Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ... BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period.The company's shares jumped 32.6% to $3.46 in premarket trading. Tracon pharmaceuticals, inc.'s shares surged 116.9% after reporting better- than-expected sales. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists ...Feb 4, 2021 · According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ... Nov 27, 2023 · The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ... LAKE FOREST, Calif., Jan. 12, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor ...
Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...
An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy. Econ Hum Biol. 2020 Aug:38:100834. doi: 10.1016/j.ehb ...Aug 10, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -... Stock Ratings Screener · Free Ratings Newsletter. This page (NASDAQ:BIOL) was last updated on 11/30/2023 by ...BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day …Nov 24, 2021 · At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ... 01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...
FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 annual meeting of stockholders scheduled to be held on May 26, 2021.
BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...
Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.Jan 25, 2023 · FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ... Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ... As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Aug 14, 2021 · You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ... May 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ...
BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.LAKE FOREST, Calif. , Nov. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial …CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today …Instagram:https://instagram. fidelity floating rate high incomeis blue shield insurance goodbest dental supplemental insuranceus saving rate BIOL. Exchange. Nasdaq. Market Cap. 2.64m. Last Price. $1.15. 52-Week Range. $1.07 - $97.50. Stock Overview. 12/01/2023 03:59 PM EST. Investor Relations. senior living real estate investingjepi vs divo NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ... sell broken iphones near me Shares in BIOLASE Inc (NASDAQ: BIOL) fell to all time lows; down 39.75% or 0.64 to 0.97. Shares in Prenetics Global Ltd (NASDAQ: PRE) fell to all time lows; falling 21.72% or 0.48 to 1.73.The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ...